Dr. Robin Jones on Olaratumab and Doxorubicin in Patients with Soft Tissue Sarcoma
3 المشاهدات
• 07/18/23
0
0
تضمين
administrator
مشتركين
Robin Jones, BSc, MB, MRCP, MD, oncologist, Royal Marsden Hospital, London, discusses the effectiveness of monoclonal antibody olaratumab in combination with doxorubicin in unresectable and metastatic soft tissue sarcoma.
For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
أظهر المزيد
تعليقات الفيسبوك
SORT BY-
أعلى تعليقات
-
أحدث تعليقات